Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Jan;75(1):50-4.
doi: 10.1136/hrt.75.1.50.

Myocardial beta adrenoceptors and left ventricular function in hypertrophic cardiomyopathy

Affiliations

Myocardial beta adrenoceptors and left ventricular function in hypertrophic cardiomyopathy

L Choudhury et al. Heart. 1996 Jan.

Abstract

Objective: To assess the relation between left ventricular function and myocardial beta adrenoceptor density.

Methods: 17 patients with hypertrophic cardiomyopathy, six with and 11 without heart failure, were studied. Left ventricular function was assessed by echocardiography, and myocardial beta adrenoceptors by positron emission tomography. Patient data were compared with those obtained in normal controls.

Results: Myocardial beta adrenoceptor density in the 17 patients was 7.00 (SD 1.90) pmol/g v 11.50 (2.18) pmol/g in normal controls (P < 0.01). beta Adrenoceptor density in the six patients with left ventricular failure was 5.61 (0.88) pmol/g v 7.71 (1.86) pmol/g in the 11 patients with normal ventricular function (P < 0.05), and there was a significant correlation (r = 0.52; P < 0.05) between left ventricular fractional shortening and myocardial beta adrenoceptor density. A positive correlation (r = 0.51; P < 0.05) was also found between myocardial beta adrenoceptor density and the E/A transmitral flow ratio, an index of left ventricular diastolic function.

Conclusions: There is myocardial beta adrenoceptor downregulation in patients with hypertrophic cardiomyopathy with or without signs of heart failure.

PubMed Disclaimer

References

    1. Chest. 1973 Jul;64(1):75-8 - PubMed
    1. Mayo Clin Proc. 1978 May;53(5):271-303 - PubMed
    1. N Engl J Med. 1982 Jul 22;307(4):205-11 - PubMed
    1. J Am Coll Cardiol. 1983 Nov;2(5):834-40 - PubMed
    1. Am J Cardiol. 1984 Apr 1;53(8):1087-94 - PubMed

Substances